Agenus, Inc. (AGEN)
6.95
-0.48
(-6.46%)
USD |
NASDAQ |
Oct 13, 16:00
7.06
+0.11
(+1.58%)
After-Hours: 20:00
Agenus Free Cash Flow : -98.50M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -98.50M |
| March 31, 2026 | -87.53M |
| December 31, 2025 | -77.20M |
| September 30, 2025 | -89.31M |
| June 30, 2025 | -127.87M |
| March 31, 2025 | -146.29M |
| December 31, 2024 | -158.89M |
| September 30, 2024 | -165.40M |
| June 30, 2024 | -180.78M |
| March 31, 2024 | -212.01M |
| December 31, 2023 | -234.16M |
| September 30, 2023 | -260.61M |
| June 30, 2023 | -239.84M |
| March 31, 2023 | -231.87M |
| December 31, 2022 | -228.44M |
| September 30, 2022 | -198.64M |
| June 30, 2022 | -41.74M |
| March 31, 2022 | -37.66M |
| December 31, 2021 | -23.67M |
| September 30, 2021 | -28.20M |
| June 30, 2021 | -169.69M |
| March 31, 2021 | -150.35M |
| December 31, 2020 | -142.56M |
| September 30, 2020 | -138.97M |
| June 30, 2020 | -135.10M |
| Date | Value |
|---|---|
| March 31, 2020 | -133.57M |
| December 31, 2019 | -23.34M |
| September 30, 2019 | -26.92M |
| June 30, 2019 | -23.62M |
| March 31, 2019 | -17.86M |
| December 31, 2018 | -134.69M |
| September 30, 2018 | -124.90M |
| June 30, 2018 | -126.68M |
| March 31, 2018 | -123.84M |
| December 31, 2017 | -97.35M |
| September 30, 2017 | -91.17M |
| June 30, 2017 | -92.91M |
| March 31, 2017 | -84.66M |
| December 31, 2016 | -92.48M |
| September 30, 2016 | -92.40M |
| June 30, 2016 | -82.86M |
| March 31, 2016 | -76.81M |
| December 31, 2015 | -50.77M |
| September 30, 2015 | -42.62M |
| June 30, 2015 | -31.76M |
| March 31, 2015 | -27.79M |
| December 31, 2014 | -41.05M |
| September 30, 2014 | -34.44M |
| June 30, 2014 | -30.59M |
| March 31, 2014 | -26.37M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Halozyme Therapeutics, Inc. | 806.22M |
| Novavax, Inc. | -43.02M |
| AVITA Medical, Inc. | -25.21M |
| Iovance Biotherapeutics, Inc. | -296.40M |
| Amgen, Inc. | 10.18B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -31.20M |
| Cash from Investing (Quarterly) | 0.267M |
| Cash from Financing (Quarterly) | 14.68M |
| Free Cash Flow Per Share (Quarterly) | -0.7547 |
| Free Cash Flow to Equity (Quarterly) | -16.91M |
| Free Cash Flow to Firm (Quarterly) | -15.84M |
| Free Cash Flow Yield | -38.36% |